Superior Planning, LLC’s Disc Medicine IRON Stock Holding History

Superior Planning, LLC’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.37K	Buy	+82	New	+$6.2K	﹤0.01%	1177

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

Superior Planning, LLC's IRON Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Disc Medicine (IRON) in Q3 2026: 82 shares worth $5.37K. The stake represents ﹤0.01% of the portfolio and ranks #1177 among its holdings.

115 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

Superior Planning, LLC held 82 shares of Disc Medicine worth $5.37K as of Q3 2026.
Disc Medicine was a new Superior Planning, LLC position in Q3 2026.
Disc Medicine made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1177 holding.
115 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.